Legislation in the genomic era: the Affordable Care Act and genetic testing for cancer risk assessment.
Chemoprevention Agents Research Development Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.|Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
Farzana L
http://orcid.org/0000-0003-0779-6972
FL
Walcott
Chemoprevention Agents Research Development Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
Barbara K
BK
Dunn
D005260:Female; D005817:Genetic Counseling; D005820:Genetic Testing / Q000941:ethics / Q000331:legislation & jurisprudence*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics / Q000517:prevention & control; D058991:Patient Protection and Affordable Care Act / Q000191:economics; D011314:Preventive Health Services / Q000191:economics / Q000331:legislation & jurisprudence; D018570:Risk Assessment / Q000331:legislation & jurisprudence; D014481:United States